- Home
- MUX vs IGMS Comparison
MUX vs IGMS Comparison
Compare MUX & IGMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MUX
- IGMS
- Stock Information
- Founded
- MUX 1979
- IGMS 1993
- Country
- MUX Canada
- IGMS United States
- Employees
- MUX N/A
- IGMS N/A
- Industry
- MUX Precious Metals
- IGMS Biotechnology: Pharmaceutical Preparations
- Sector
- MUX Basic Materials
- IGMS Health Care
- Exchange
- MUX Nasdaq
- IGMS Nasdaq
- Market Cap
- MUX 524.8M
- IGMS 82.1M
- IPO Year
- MUX N/A
- IGMS 2019
- Fundamental
- Price
- MUX $11.42
- IGMS $1.36
- Analyst Decision
- MUX Strong Buy
- IGMS Hold
- Analyst Count
- MUX 2
- IGMS 8
- Target Price
- MUX $15.25
- IGMS $6.00
- AVG Volume (30 Days)
- MUX 924.4K
- IGMS 1.1M
- Earning Date
- MUX 08-06-2025
- IGMS 08-13-2025
- Dividend Yield
- MUX N/A
- IGMS N/A
- EPS Growth
- MUX N/A
- IGMS N/A
- EPS
- MUX N/A
- IGMS N/A
- Revenue
- MUX $168,945,000.00
- IGMS $2,681,000.00
- Revenue This Year
- MUX N/A
- IGMS $134.30
- Revenue Next Year
- MUX $0.31
- IGMS $22.37
- P/E Ratio
- MUX N/A
- IGMS N/A
- Revenue Growth
- MUX N/A
- IGMS 27.36
- 52 Week Low
- MUX $6.38
- IGMS $0.92
- 52 Week High
- MUX $11.46
- IGMS $22.50
- Technical
- Relative Strength Index (RSI)
- MUX 76.46
- IGMS 59.58
- Support Level
- MUX $9.25
- IGMS $1.12
- Resistance Level
- MUX $11.24
- IGMS $1.39
- Average True Range (ATR)
- MUX 0.43
- IGMS 0.08
- MACD
- MUX 0.15
- IGMS 0.01
- Stochastic Oscillator
- MUX 100.00
- IGMS 83.87
About MUX McEwen Mining Inc.
McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company primarily generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, most production occurs in the United States.
About IGMS IGM Biosciences Inc.
IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, Aplitabart: An IgM antibody targeting Death Receptor 5 (DR5) proteins, for the treatment of colorectal cancer; Imvotamab: A bispecific for severe systemic lupus erythematosus (SLE) and one for severe rheumatoid arthritis (RA); and IGM-2644: A bispecific T cell engaging IgM antibody targeting CD38 and CD3 proteins, currently planned for evaluation in autoimmune disease.